SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Escalon Medical Corp – ‘10-Q’ for 12/31/19 – ‘EXCEL’

On:  Friday, 2/14/20, at 4:02pm ET   ·   For:  12/31/19   ·   Accession #:  862668-20-2   ·   File #:  0-20127

Previous ‘10-Q’:  ‘10-Q’ on 11/14/19 for 9/30/19   ·   Next:  ‘10-Q’ on 5/14/20 for 3/31/20   ·   Latest:  ‘10-Q’ on 2/14/24 for 12/31/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/14/20  Escalon Medical Corp              10-Q       12/31/19   51:4.4M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    372K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     23K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     23K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     18K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     18K 
45: R1          Document And Entity Information                     HTML     44K 
31: R2          Consolidated Balance Sheets                         HTML    116K 
15: R3          Consolidated Balance Sheets (Parenthetical)         HTML     32K 
40: R4          Consolidated Statements Of Operations               HTML     87K 
46: R5          Consolidated Statements Of Shareholders' Equity     HTML     49K 
                and Comprehensive Loss                                           
32: R6          Consolidated Statements Of Cash Flows               HTML     94K 
16: R7          Organization and Description of Business            HTML     22K 
41: R8          Going concern (Notes)                               HTML     22K 
44: R9          Significant Accounting Policies                     HTML    139K 
36: R10         Discontinued operation (Notes)                      HTML     56K 
48: R11         Related Party Transactions                          HTML     27K 
26: R12         Line of credit (Notes)                              HTML     24K 
20: R13         Concentration of credit risk (Notes)                HTML     47K 
35: R14         Retirement and post retirement plans (Notes)        HTML     22K 
47: R15         Significant Accounting Policies (Policies)          HTML    258K 
25: R16         Leases (Policies)                                   HTML     88K 
19: R17         Significant Accounting Policies (Tables)            HTML    115K 
34: R18         Concentration of credit risk (Tables)               HTML     50K 
49: R19         Retirement and post retirement plans (Tables)       HTML     19K 
28: R20         Inventories (Tables)                                HTML     40K 
14: R21         Leases (Tables)                                     HTML    135K 
39: R22         Going concern (Details)                             HTML     19K 
43: R23         Significant Accounting Policies (Cash and Cash      HTML     21K 
                Equivalents) (Details)                                           
27: R24         Significant Accounting Policies (Inventory)         HTML     28K 
                (Details)                                                        
13: R25         Significant Accounting Policies (Accounts           HTML     18K 
                Receivable) (Details)                                            
38: R26         Significant Accounting Policies (Net Income (loss)  HTML     32K 
                Per Share) (Details)                                             
42: R27         Significant Accounting Policies Earning per share   HTML     65K 
                details (Details)                                                
29: R28         Significant Accounting Policies Goodwill and        HTML     18K 
                intangible assets (Details)                                      
12: R29         Significant Accounting Policies deferred revenue    HTML     23K 
                (Details)                                                        
17: R30         Discontinued operation (Details)                    HTML     37K 
23: R31         Related Party Transactions (Details)                HTML     46K 
50: R32         Line of credit (Details)                            HTML     56K 
37: R33         Concentration of credit risk (Details)              HTML     89K 
18: R34         Revenue from contracts with customers (Details)     HTML     23K 
24: R35         Retirement and post retirement plans (Details)      HTML     31K 
51: R36         Leases (Details)                                    HTML     64K 
30: R9999       Uncategorized Items - esmc-20191231.xml             HTML     20K 
21: XML         IDEA XML File -- Filing Summary                      XML     85K 
22: EXCEL       IDEA Workbook of Financial Reports                  XLSX     53K 
 6: EX-101.INS  XBRL Instance -- esmc-20191231                       XML   1.19M 
 8: EX-101.CAL  XBRL Calculations -- esmc-20191231_cal               XML    126K 
 9: EX-101.DEF  XBRL Definitions -- esmc-20191231_def                XML    399K 
10: EX-101.LAB  XBRL Labels -- esmc-20191231_lab                     XML    945K 
11: EX-101.PRE  XBRL Presentations -- esmc-20191231_pre              XML    576K 
 7: EX-101.SCH  XBRL Schema -- esmc-20191231                         XSD     88K 
33: ZIP         XBRL Zipped Folder -- 0000862668-20-000002-xbrl      Zip    142K 


‘EXCEL’   —   IDEA Workbook of Financial Reports


This is an IDEA Workbook.

        Download this Microsoft® Excel® .xlsx workbook

Top
Filing Submission 0000862668-20-000002   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 9, 4:34:49.1pm ET